DRKS00005282已完成不适用
Epoetin alfa HEXAL® in oncology and haematology patients with chemotherapy induced anaemia. A noninterventional observational study. - OncoBOS
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- Hexal AG
- 入组人数
- 440
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 Years 至 one（—）
- 性别
- All
入选标准
- •1. Diagnosis of solid tumour, malignant lymphoma or multiple myeloma;
- •2. Tumour therapy with chemotherapy alone or in combination with other therapies;
- •3.Therapy with Epoetin alfa HEXAL for symptomatic anaemia and a reduction of transfusions is planned for three to six chemotherapy cycles;
- •4. Written informed consent of patients available covering pro- and retrospective pseudonymised documentation, transmission and analysis of data as well as inspection of data during monitoring.
排除标准
- •1. Patient is treated within another study;
- •2. Tumour therapy consists of radiation alone;
- •3. Patient suffers from acute leucaemia or chronic myeloproliferative syndrome;
- •4. Patient suffers from non-treated haemolytic anaemia or from iron, vitamin B12 or folic acid deficiency anaemia not related to the tumour;
- •5. Patient has participated in the same study earlier;
- •6. Contraindications to Epoetin alfa HEXAL according to the current summary of product characteristics.
- •7. Female patients: Pregnancy or breast-feeding.
研究者
相似试验
进行中（未招募）
不适用
Epoetin alfa HEXAL® in Chemotherapy induced Anaemia and Evolution of Cardiomyopathy under Anthracyclines - A non-interventional studyChemotherapy induced anaemia under anthracycline therapyD61.10DRKS00004219HEXAL AG2
已完成
2 期
Efficacy of Aprepitant for Hematology and Oncology.Hematological cancerJPRN-UMIN000005705Kyoto University Hospital,Department of Hematology and Oncology52
已完成
4 期
Epoetin Alfa (Hemax®) Phase IV Study in Chemotherapy Induced AnemiaAntineoplastic Chemotherapy Induced AnemiaNCT01374373Bio Sidus SA30
已完成
2 期
A Study to Determine the Effectiveness of Epoetin Alfa in Facilitating Self-donation of Blood Before Surgery in Non-anemic Patients Who Are Undergoing Orthopedic, Heart and Blood Vessel, or Breast Reduction Surgery; Performed in Combination With a Procedure to Reduce Blood Loss During Surgery.Blood TransfusionBlood Transfusion, AutologousOrthopedic ProceduresOrthopedic SurgeryCardiovascular Surgical ProceduresMammaplastyNCT00270023Johnson & Johnson Pharmaceutical Research & Development, L.L.C.112
已完成
3 期
Epoetin Alfa With or Without Dexamethasone in Treating Fatigue and Anemia in Patients With Hormone-Refractory Prostate CancerFatigueProstate CancerAnemiaNCT00060398Eastern Cooperative Oncology Group282